Shandong Weigao Group Medical Polymer Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 2/6

Shandong Weigao Group Medical Polymer verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 4.2%, während die Gewinne der Branche Medical Equipment jährlich um gewachsen und zwar um 14.7%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 6.4%. Die Eigenkapitalrendite von Shandong Weigao Group Medical Polymer beträgt 8% und die Nettomargen betragen 14.7%.

Wichtige Informationen

4.2%

Wachstumsrate der Gewinne

4.0%

EPS-Wachstumsrate

Medical Equipment Wachstum der Industrie	13.7%
Wachstumsrate der Einnahmen	6.4%
Eigenkapitalrendite	8.0%
Netto-Marge	14.7%
Letzte Ertragsaktualisierung	30 Jun 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Aufschlüsselung der Einnahmen und Ausgaben

Wie Shandong Weigao Group Medical Polymer Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

SZSC:1066 Einnahmen, Ausgaben und Erträge (CNY Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten	F&E-Ausgaben
30 Jun 24	12,967	1,912	3,778	600
31 Mar 24	13,098	1,957	3,807	596
31 Dec 23	13,229	2,002	3,837	593
30 Sep 23	13,398	2,221	3,793	597
30 Jun 23	13,566	2,440	3,748	602
31 Mar 23	13,657	2,602	3,721	579
31 Dec 22	13,747	2,764	3,694	556
30 Sep 22	13,903	2,676	3,725	551
30 Jun 22	14,058	2,589	3,755	546
31 Mar 22	13,633	2,432	3,793	525
31 Dec 21	13,209	2,276	3,830	503
30 Sep 21	12,923	2,288	3,865	493
30 Jun 21	12,636	2,300	3,900	484
31 Mar 21	12,129	2,194	3,775	454
31 Dec 20	11,622	2,087	3,651	424
30 Sep 20	11,139	1,998	3,636	403
30 Jun 20	10,656	1,909	3,622	382
31 Mar 20	10,520	1,879	3,699	394
31 Dec 19	10,384	1,850	3,776	406
30 Sep 19	9,993	1,805	3,696	374
30 Jun 19	9,602	1,760	3,615	341
31 Mar 19	9,205	1,616	3,500	326
31 Dec 18	8,809	1,473	3,385	311
30 Jun 18	7,465	1,255	2,842	280
31 Mar 18	6,879	1,255	2,593	277
31 Dec 17	6,293	1,255	2,344	274
30 Jun 17	5,402	1,297	1,918	258
31 Mar 17	5,511	1,165	2,062	262
31 Dec 16	5,620	1,033	2,206	266
30 Sep 16	6,484	1,010	2,469	302
30 Jun 16	6,237	914	2,367	302
31 Mar 16	6,078	1,013	2,153	297
31 Dec 15	5,919	1,113	1,938	293
30 Sep 15	5,878	1,237	1,920	290
30 Jun 15	5,610	1,196	1,839	262
31 Mar 15	5,548	1,161	1,828	252
31 Dec 14	5,278	1,085	1,742	238
30 Sep 14	5,011	307	1,646	222
30 Jun 14	4,996	431	1,583	222
31 Mar 14	4,769	376	1,521	215
31 Dec 13	4,613	388	1,453	209

Qualität der Erträge: 1066 hat hohe Qualitätseinkünfte.

Wachsende Gewinnspanne: 1066Die aktuellen Gewinnspannen (14.7%) sind niedriger als im letzten Jahr (18%).

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: 1066In den letzten 5 Jahren sind die Gewinne von 4.2% jährlich gestiegen.

Beschleunigtes Wachstum: 1066Das Unternehmen hat im vergangenen Jahr ein negatives Gewinnwachstum verzeichnet, so dass es nicht mit seinem 5-Jahres-Durchschnitt verglichen werden kann.

Erträge im Vergleich zur Industrie: 1066 hatte im vergangenen Jahr ein negatives Gewinnwachstum (-21.6%), was einen Vergleich mit dem Branchendurchschnitt Medical Equipment (-4.3%) erschwert.

Eigenkapitalrendite

Hohe Eigenkapitalrendite: 1066Die Eigenkapitalrendite des Unternehmens (8%) wird als niedrig angesehen.

Shandong Weigao Group Medical Polymer Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

First half 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.27 in 1H 2023)

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2024 Results on Aug 28, 2024

Full year 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.61 in FY 2022)

Full year 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.60 in FY 2022)

Shandong Weigao Group Medical Polymer Company Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

First half 2023 earnings released: EPS: CN¥0.27 (vs CN¥0.34 in 1H 2022)

Recent updates

Shandong Weigao Group Medical Polymer Company Limited Approves the Distribution of Interim Dividend for the Six Months Ended 30 June 2024, Payable on 22 November 2024

Investor sentiment deteriorates as stock falls 17%

Upcoming dividend of CN¥0.092 per share

Investor sentiment improves as stock rises 16%

First half dividend of CN¥0.092 announced

First half 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.27 in 1H 2023)

Shandong Weigao Group Medical Polymer Company Limited Proposes an Interim Dividend for the Six Months Ended 30 June 2024, Payable on Before 22 November 2024

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2024 Results on Aug 28, 2024

Shandong Weigao Group Medical Polymer Company Limited Approves Board Appointments

Upcoming dividend of CN¥0.094 per share

Full year 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.61 in FY 2022)

Final dividend of CN¥0.094 announced

Shandong Weigao Group Medical Polymer Company Limited, Annual General Meeting, May 28, 2024

Full year 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.60 in FY 2022)

Shandong Weigao Group Medical Polymer Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024

Shandong Weigao Group Medical Polymer Company Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023

Investor sentiment deteriorates as stock falls 18%

Shandong Weigao Group Medical Polymer Company Limited Announces the Resignation of Ni Has Tendered as Executive Director, Effective from 31 December 2023

Shandong Weigao Group Medical Polymer Company Limited Approves Distribution of Interim Dividend for the Six Months Ended 30 June 2023

Upcoming dividend of CN¥0.073 per share at 2.4% yield

First half 2023 earnings released: EPS: CN¥0.27 (vs CN¥0.34 in 1H 2022)

Shandong Weigao Group Medical Polymer Company Limited Proposes Interim Dividend for the Six Months Ended 30 June 2023, Payable on 24 November 2023

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2023 Results on Aug 29, 2023

Now 21% undervalued after recent price drop

Shandong Weigao Group Medical Polymer Company Limited Approves Final Dividend for the Year Ended 31 December 2022, Payable on or Before 14 July 2023

Upcoming dividend of CN¥0.079 per share at 1.5% yield

Full year 2022 earnings released: EPS: CN¥0.60 (vs CN¥0.51 in FY 2021)

Shandong Weigao Group Medical Polymer Company Limited Appoints Li Qiang as an Independent Non-Executive Director

Key Executive recently sold HK$5.8m worth of stock

Now 22% undervalued

Less than half of directors are independent

Shandong Weigao Group Medical Polymer Company Limited Announces Resignation of Wang Jinxia as an Independent Non-Executive Director of the Company, A Member of Audit Committee, A Member of Remuneration Committee, A Member of Nomination Committee and A Member of Corporate Governance Committee

Now 20% undervalued

Shandong Weigao Group Medical Polymer Company Limited Approves Interim Dividend for the Six Months Ended June 30, 2022, Payable on November 11, 2022

Upcoming dividend of CN¥0.086 per share

Shandong Weigao Group Medical Polymer Company Limited (SEHK:1066) agreed to acquire Weihai Weigao Medical Materials Company Limited from Weigao Holding Company Limited for approximately RMB288.0 million.

First half 2022 earnings released: EPS: CN¥0.32 (vs CN¥0.27 in 1H 2021)

Shandong Weigao Group Medical Polymer Company Limited Announces Executive Changes

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2022 Results on Aug 22, 2022

Investor sentiment improved over the past week

Shandong Weigao Group Medical Polymer Company Limited Approves Executive Appointments

Upcoming dividend of CN¥0.065 per share

Now 22% undervalued after recent price drop

Full year 2021 earnings released: EPS: CN¥0.50 (vs CN¥0.47 in FY 2020)

Less than half of directors are independent

Shandong Weigao Group Medical Polymer Company Limited Announces Executive Resignations

Shandong Weigao Group Medical Polymer Company Limited, Annual General Meeting, Jun 06, 2022

Full year 2021 earnings released: EPS: CN¥0.50 (vs CN¥0.45 in FY 2020)

Shandong Weigao Group Medical Polymer Company Limited Recommends Final Dividend for the Year Ended December 31, 2021

Investor sentiment improved over the past week

Shandong Weigao Group Medical Polymer Company Limited to Report Q4, 2021 Results on Mar 29, 2022

Upcoming dividend of CN¥0.077 per share

First half 2021 earnings released: EPS CN¥0.27 (vs CN¥0.22 in 1H 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Shandong Weigao Group Medical Polymer Company Limited Approves Final Dividend for the Year Ended December 31, 2020 At the Annual General Meeting Held on May 24, 2021

Upcoming dividend of CN¥0.068 per share

Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.41 in FY 2019)

Chairman & Compliance Officer Hua Wei Zhang has left the company

Executive Vice Chairman Yi Wang has left the company

Shandong Weigao Group Medical Polymer Company Limited Approves the Appointment of Tang Zheng Peng as a Non-Executive Director of the Company

New 90-day low: HK$13.28

Shandong Weigao Group Medical Polymer Company Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

Chairman & Compliance Officer recently sold HK$14m worth of stock

New 90-day high: HK$17.06

Shandong Weigao Group Medical Polymer Company Limited Announces Director Changes

New 90-day low: HK$14.22

New 90-day low: HK$14.82